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ABSTRACT 
 
Analgesic and anti-inflammatory tests of eel (Anguilla bicolor bicolor) oil on animal models 
have been performed. Previous studies have proven that oral administration of EPA and DHA exhibits 
analgesic and anti-inflammatory effects. Gas Chromatography analysis shows that eel contains EPA 
and DHA. In this research, the analgesic activity was evaluated with the acetic acid-induced writhing 
test and hot plate test, while the anti-inflammatory properties were identified using carrageenan-
induced inflammation. In the writhing test, 25 male Swiss Webster mice were divided into five groups. 
Group I was given 0.5% CMC-Na as a negative control, group II was given 65 mg/kg b.w. of Acetosal 
as a positive control, group III-V was given eel oil at different doses, namely 2400, 4800, and 9600 
mg/kg b.w. of the mouse. For the hot plate test, 6.5 mg/kg b.w. of tramadol acted as the positive 
control. Similar to the analgesic effect analysis, the anti-inflammatory test also divided 25 male Wistar 
rats into five groups. Group I as a negative control was given 0.5% CMC-Na,  group II was given 9 
mg/kg b.w. of diclofenac potassium as a positive control, and group III-V were given eel oil at 
different doses, namely 1500, 3000, and 6000 mg/kg b.w. of the rat. The results of the acetic acid-
induced writhing test and hot plate test showed that when compared with the positive and negative 
controls, eel oil had a potential analgesic activity with a significance value of p< 0.05. The analgesic 
effects were noticeable at doses of 2400, 4800 and 9600 mg/kg b.w. in the writhing test and at 4800 
and 9600 mg/kg b.w. in the hot plate test. The anti-inflammatory test showed that eel oil was 
efficacious when administered at the doses of 1500, 3000, and 6000 mg/kg b.w. with percentage 
inhibition of 34.35%, 35.132%, and 40.28%, respectively. 
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INTRODUCTION 
Pain and inflammation are the most common physical conditions in many people that can be 
indicated as a symptom of a disease. Pain is defined as an unpleasant physical sensation that differs in 
type, intensity, duration, and location (Lambert, 2014). Inflammation is an essential immune response 
that enables survival during infection or injury and maintains tissue homeostasis under a variety of 
noxious conditions (Medzhitov, 2010). Pain and inflammation with mild to moderate intensity can 
effectively be treated using a particular drug class, viz., Non-Steroidal Anti-Inflammatory Drugs 
(NSAIDs) (Swieboda et al., 2013). However, more intense pain requires non-dependent analgesics, 
such as tramadol (Mullican et al., 2001). In the U.S., around 43 million adults (19.0%) take aspirin at 
least three times per week for more than three months (i.e., regular users), and more than 29 million 
adults (12.1%) are regular users of NSAIDs (Zhou et al., 2014).  
NSAIDs are commonly used for arthritis pain worldwide, although long-term use may have side 
effects (Conaghan, 2012). Long-term use of NSAIDs is associated with adverse events involving the 
gastrointestinal system (Castellsague et al., 2012; Sostres et al., 2010) and the cardiovascular system 
(Atzeni et al., 2010; Olsen et al., 2011). Tramadol is an opioid analgesic drug used in treating 
moderate to severe pain (Rafati et al., 2012). The use of tramadol can cause many side effects, such as 
nausea, vomiting, dizziness, itching, shortness of breath, dry mouth, sweating, and psychological 
dependence. 
The marine product is the new drug discovery for health. The role of natural products in drug 
discovery has undergone many changes in the past 30 years, with a noticeable decline in participation 
by the major pharmaceutical companies by the mid-1990s (Molinski et al., 2009). Eel (Anguilla 
bicolor bicolor) is one of marine biodiversity and generally consumed fish in many countries, 
especially Japan, China, Germany, and France (Sasongko et al., 2017). Eel oil is reported to contain 
fatty acids like eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (Baeza et al., 2014; 
Kusharto et al., 2014). EPA and DHA are part of Omega-3 polyunsaturated fatty acids (Amissi et al., 
2016). Many studies report that EPA and DHA can reduce inflammation (Camuesco et al., 2005; 
James et al., 2000; Mori and Beilin, 2004; Simopoulos, 2002) and pain (Goldberg and Katz, 2007). 
The anti-inflammatory nature of DHA- and DPA-derived EFOX (electrophilic oxo-derivatives) by 
showing that they can act as peroxisome proliferator-activated receptor gamma (PPAR gamma) 
agonists and inhibit pro-inflammatory cytokines and nitric oxide production, all within the biological 
concentration ranges (Groeger et al., 2010). 
This paper discusses the analgesic and anti-inflammatory effects of eel (Anguilla bicolor 
bicolor) oil. In the literature, there has never been a study performing analgesic and anti-inflammatory 
test on eel oil. The analgesic testing used writhing and hot plate test (Sasongko et al., 2016; Fan et al., 
2014), while the anti-inflammatory analysis used carrageenan to induce inflammation (Shalini et al., 
2015). 
 
 
MATERIALS AND METHODS  
Chemicals 
Acetosal (Merck), potassium diclofenac (Hexpharm), tramadol (Kimia Farma) were purchased 
from Apotek Sebelas Maret Surakarta. The carrageenan was bought from Sigma Lumda. The Distilled 
water, CMC 0.5%, acetic acid glacial (Merck), NaCl 0.9%, NaOH, Na2SO4, and analytical grade 
methanol were obtained from the Pharmaceutical and Pharmacology Laboratory, Faculty of 
Mathematics and Natural Sciences, Universitas Sebelas Maret. 
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Animals 
The experiment used Wistar rat (weighing 150-200 gram) for the anti-inflammation test and 
Swiss Webster mice (weighing 20-30 gram) for the analgesic test. The test animals were 
locally purchased from Mouse for Labs, Mojosongo, Boyolali, Jawa Tengah. 
 
Eel for material test 
Eels (Anguilla bicolor bicolor) aged 6-8 months and weighing 100-200 g were purchased from 
the UNAGI business development unit, Universitas Sebelas Maret, Surakarta. 
 
Oil extraction 
The reflux extraction technique was performed to extract oil from fresh eels. Eels were cut into 
small pieces and then refluxed using distilled water under a controlled temperature (70-80ᵒC) for ± 5 
hours. The oil phase was then centrifuged at 3000 rpm and separated using a filter paper (Sasongko et 
al., 2017).  
 
Identification of EPA and DHA  
The oil of eel extract was tested for its EPA and DHA content, which was determined by gas 
chromatography. A total of 30-40 mg of eel oil was placed in a closed tube, added with 1 mL of 
NaOH 0.5 N in methanol, and heated in a water bath for 20 minutes. Then, the oil was added with 2 
mL of 20% BF3 and reheated for 20 minutes. After the oil had cooled down, it was added with 2 mL 
of saturated NaCl and 1 mL of isooctane, then was shaken well. The isooctane layer was separated 
with the help of a dropper, then transferred into a tube containing 0.1 g of Na2SO4 and left for 15 
minutes. The liquid phase was separated and subsequently injected into the gas chromatogram. To 
determine the retention time of EPA and DHA, gas of fatty acid ester from the Fatty Acid Methyl 
Ester (FAME) standard, which containe EPA and DHA as the standard, was injected first into the 
chromatogram. The presence of EPA and DHA in the samples can be viewed by equalizing the 
retention time of the EPA and DHA standard (Panagan et al., 2011). 
 
Preparation of test animals 
The rats and white mice were acclimatized for one week and given sufficient food and drink. 
Before the test, they were subjected to fasting for ± 11 hours, without food but still provided with 
drinking water. This procedure aimed to reduce the effects of bias during the study. All research 
protocols that involved test animals had been approved by the ethics committee of the Faculty of 
Medicine, Universitas Sebelas Maret (No. 441/V/HREC/2017). 
 
Analgesic test 
Acetic Acid-Induced Writhing Test 
The analgesic test was performed by giving the test material orally. After 5 minutes, an 
intraperitoneal administration of acetic acid 1% was conducted. Pain is characterized by the onset of 
writhing or stretching, i.e., when the abdomen of the mice touches the floor of the testing area and both 
front and hind legs are pulled back (Sasongko et al., 2016). The mice were divided into five groups 
randomly before the experiment. Group I was given 0.5% CMC-Na as a negative control, group II was 
given 65 mg/kg b.w. of Acetosal as a positive control, group III-V was given eel oil at the doses of 
2400, 4800, and 9600 mg/kg b.w of the mouse. The number of writhing episodes in 30 minutes was 
counted for each group. When compared with the negative control, a smaller number of writhing 
episodes signifies an analgesic activity in the test animal (Goenarwo et al., 2011).  
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E = cumulative total of writhing episodes in the test animals after intervention 
C = cumulative total of writhing episodes in the negative control 
 
Hot plate test 
The analgesic activity was also evaluated using the hot plate method. The mice were placed on a 
hot plate maintained at 55ºC. Jumping from the plate and latency period (the first jump after exposure 
to heat) are considered as a response to pain stimulus (Mondal et al., 2014). Reaction time for each 
group was recorded at 15, 30, 45, 60, 90 and 120 minutes after drug administration. To avoid any 
severe tissue damage, a cutoff point of 45 seconds was considered (Fan et al., 2014). The mice were 
divided into five groups. Group I was given 0.5% CMC-Na as a negative control, group II was given 
6.5 mg/kg b.w. of tramadol as a positive control, and group III, IV and V were given eel oil at different 
doses, namely 2400 mg, 4800 mg, and 9600 mg/kg b.w. The number of jumps and latency period in 
each group were calculated and then averaged. Afterward, the analgesic intervention groups were 
compared with the negative control. The percentage (%) of analgesic protection was calculated using 
the two formula below: 
 
Analgesic protection based on the latency period: 
 
 
 
 
 
 
   LPt = Latency period to treatment 
   LPn = Latency period for negative control 
 
Analgesic protection based on the number of jumps: 
 
 
 
 
E = cumulative total of jumps in the test animals after treatment 
C = cumulative total of jumps in the negative control 
 
Anti-inflammation test 
The anti-inflammatory test in this study relied on the formation of artificial edema. The rat’s 
legs were identified with markers and measured in volume using a plethysmometer. After the test rats 
were given the drug and allowed for 30-minute rest, 0.1 mL of 1% carrageenan was injected. The 
needle was inserted in the same direction as the rat's leg. The volume of edema was measured every 15 
minutes from Minute 0 to 180. The rats were divided into five groups randomly before the experiment. 
Group I was given 0.5% CMC-Na as a negative control, group II was given 9 mg/kg b.w. of diclofenac 
potassium as a positive control, and group III, IV and V were given eel oil at the doses of 1500, 3000, 
and 6000 g/kg b.w., respectively. The data of edema volume before and during the treatment were 
used to calculate the percentage of increase in the edema volume at t time, as shown in the following 
equations. 
 
 % analgesic protection  = 100% - [(E/C) x 100] 
%]  
 
x 100 
       (LPt- LPn)  
 
     (45 sec- LPn) 
 % analgesic protection  = 
% writhing protection = 100 – [(E/C) x 100%] 
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 ………….. (a) 
…………. (b) 
Percentage of anti-inflammation = ……………. (c) 
 
Statistical analysis  
The data were analyzed statistically with the Shapiro-Wilk test for normality and the test for 
homogeneity of variance. The normally and homogenously distributed data were analyzed with One-
way Analysis of Variance (ANOVA). To identify the differences among the treatment groups, the 
research employed LSD and Bonferroni post hoc test. As for the data that were not distributed 
normally and homogenously, they were subjected to the Kruskal-Wallis test, followed with the Mann-
Whitney U test.  
 
RESULTS AND DISCUSSION  
Extraction yield and EPA and DHA content  
The extraction of eel (Anguilla bicolor bicolor) with a gross weight of 1 kg yielded 5.65% w/w. 
This yield is almost the same as the one produced in the previous research, i.e., 5.33% w/w with a 
specific gravity of 0.8575 g/mL (Sasongko et al., 2017). The results of the EPA and DHA analysis of 
the eel oil extract were shown in Table I. 
 
Table I. EPA and DHA contents in eel (Anguilla bicolor bicolor) oil 
 
Parameters Results Unit 
Eicosapentaenoic acid (EPA) 843.4 mg/100 g 
Docosahexaenoic acid (DHA) 3045.8 mg/100 g 
 
The EPA and DHA contents in eel were used as active compounds in the analgesic and anti-
inflammatory testing. A previous study found that fresh Indonesian eel is composed of 1.15% EPA 
and 5.16% DHA (Kusharto et al., 2014). Fish oil is rich in omega-3, which is an unsaturated fatty acid 
containing two fatty acids, namely Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) 
(Almatsier, 2002). Figure 1 shows the chemical structures of EPA and DHA. 
 
 
Figure 1. The chemical structures of EPA and DHA (Hadipranoto, 2010) 
 
The analgesic effect of eel (Anguilla bicolor bicolor) oil 
Acetic acid-induced writhing test 
The test animals received 1% acetic acid to induce pain. This chemical causes severe irritation 
on the mucous membrane of the abdominal cavity. This pain is manifested in the extension of legs, 
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arching of the back, and contraction of the abdomen―causing it to touch the floor of the treatment 
site) (Sasongko et al., 2016). The data generated from the test include the number of writhing 
episodes. The average of the writhing episodes in each group is presented in Table II. 
 
Table II. The cumulative number of writhing episodes in each group of mice after stretch induction  
by 0.5% acetic acid 
 
Groups Average of 
writhing 
episodes   
% writhing  
protection 
Post hoc test 
(p) 
Negative control  191.6±17.3  0%  
Positive control 41.2±8.01 78.5% .009* 
Eel oil 2400 mg/kg b.w. 167.4±10.09 12.63% .016* 
Eel oil 4800 mg/kg b.w. 114.6±13.47 40.19% .047* 
Eel oil 09600 mg/kg b.w. 38.2±4.09 80.06% .009* 
* significant difference with the negative control (p<0.05) 
 
Table II shows that the negative control―given 0.5% CMC-Na―causes the highest number of 
writhing episodes. In this case, 0.5% CMC-Na is a placebo that has no analgesic activity, resulting in 
the highest writhing episodes among the test animals. Because the administration of Acetosal, as a 
positive control, induced a smaller number of writhing episodes than the negative control, the test 
method is concluded as valid. Acetosal is a non-steroid anti-inflammatory drug (NSAID) that inhibits 
the activity of the enzyme called cyclooxygenase (COX), which leads to the formation of 
prostaglandins (PGs)―i.e., a precursor of inflammation, swelling, pain, and fever (Vane and Botting, 
2003). There are two structurally distinct forms of the cyclooxygenase enzyme (COX-1 and COX-2). 
COX-1 is a constitutive member of normal cells, while COX-2 is induced in inflammatory cells. 
Inhibition of COX-2 activity represents the most likely mechanism of NSAID-mediated analgesia 
(Cashman, 1996). As seen in Table II, the cumulative writhing episodes in groups receiving eel oil at 
the doses of 2400, 4800, and 9600 mg/kg b.w. are averagely 167.4 ± 10.09, 114.6±13.47, and 
38.2±4.09. When administered at the dose of 9600 mg/kg b.w., the number of writhing episodes is not 
significantly different from the positive control (p≥ 0.05). The administration of eel oil reveals that a 
higher dose leads to fewer writhing episodes and, in other words, higher protection against writhing 
(p≤ 0.05).  Eel oil (Anguilla bicolor bicolor) is used as an analgesic in this research because it has EPA 
and DHA content. EPA and DHA are included in the essential fatty acids that are released due to the 
presence of wound on the cell membranes, which then competitively inhibit the formation of pro-
inflammatory interleukins (IL-1β, IL-6, and IL-12), tumor necrosis factor alpha (TNF α), and 
prostaglandin. Pro-inflammatory cytokines, such as IL-1β, IL-6, and TNF-α, can lead to pathological 
pain (Zhang and An, 2007). EPA has a long-chain structure like AA (Arachidonic Acid); therefore, it 
can be a competitor that replaces arachidonic acid in the metabolic processes of cyclooxygenase and 
lipoxygenase. EPA is also a substrate of COX, LPO, and cytochrome P450 enzymes that produce 
eicosanoids. Mediators generated by EPA have different structures, such as PGE3 (EPA) and PGE2 
(AA) as well as LTB5 (EPA) and LTB4 (AA) (Calder, 2013). 
 
Hot plate test 
Hot plate test is a widely used model for centrally acting analgesics through their action at the 
spinal cord level. Pain caused by heat exposure is very closely related to the ability of high 
temperature to damage the tissue on mice. Tissue damage will occur at > 45ºC, and, as a result, the 
sensation of heat will turn into pain (Puspitasari et al., 2003). Reaction to thermal pain such as 
jumping in mice is considered to be a supraspinally integrated response (Fan et al., 2014). An average 
number of jumps and the latency period generated from each group can be seen in Tables III and IV. 
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Table III. The cumulative data of jumps in each group of mice 
 
Groups Average of   
jumps 
% analgesic 
protection 
Post hoc test 
Negative control (Aquadest) 15.82±1.49    
Positive control (Tramadol) 6.28±1.58 60.30% .012* 
Eel oil 2400 mg/kg b.w. 15.77±2.14 0.32% .911 
Eel oil 4800 mg/kg b.w. 8.43±1.83 46.77% .045* 
Eel oil 9600 mg/kg b.w. 6.97±0.46 55.94% .021* 
* significant difference with negative control 
 
Table IV. The cumulative data of the latency period in each group of mice 
 
Groups Average of   
latency period  
% analgesic 
protection 
Post hoc test 
Negative control (Aquadest) 8.7±1.45   
Positive control (Tramadol) 19.18±2.83 28.87% .009* 
Eel oil 2400 mg/kg b.w. 9.9±7.85 3.3% .016* 
Eel oil 4800 mg/kg b.w. 16.03±4.25 26.61% .009* 
Eel oil 9600 mg/kg b.w. 20.63±2.79 32.86% .009* 
* significant difference with negative control 
 
Tables II and III present the central analgesic activity showed during the hot plate method. The 
negative control has the most number of jumps and the shortest latency period because aquadest is 
pure water that does not contain any ingredients (Linandarwati, 2010) and, thereby, exhibits no 
activity in reducing central pain. Tramadol was chosen as a positive control because it belongs to the 
opioid group and is a drug of choice in the group of analgesics that work centrally. Furthermore, the 
positive control has the smallest average number of jumps and the most extended latency period 
compared with the negative control, which means that the test method is valid and that tramadol is 
effective in treating central pain.  
At a higher dose, the administration of eel oil induces a fewer number of jumps and more 
extended latency period. The percentage of analgesic protection based on jumps and latency period 
becomes more significant as the dose of eel oil increases, i.e., from 2400 mg to 4800 mg then 9600 
mg/kg b.w. According to Winarti and Wantiyah (2011), a high percentage of analgesic protection 
implies that the test animal can withstand the pain caused by thermal exposure to its feet. When 
administered at the doses of 4800 and 9600 mg/kg b.w., the eel oil showed no significant difference in 
the percentage of analgesic protection compared with the positive control. 
Eel oil contains omega-3 (EPA and DHA), which is known to have many benefits. Also, some 
studies have affirmed that omega-3 in fish oil can reduce pain. DHA can release β-endorphin that 
stimulates µ receptor―that is, receptors associated with the occurrence of pain, especially central pain. 
If the receptor is stimulated, there will be no release of neurotransmitters in the body (Laino, 2017). In 
other words, the body does not experience any pain. 
 
The anti-inflammatory effect of eel (Anguilla bicolor bicolor) oil 
An anti-inflammatory test aims to determine the association of a decrease in the volume of the 
food pad (edema) in rats with the administration of eel oil. In this study, the edema was induced by 
intraplantar injection of carrageenan. Carrageenan can release prostaglandins that trigger inflammation 
in rat's legs. Inflammation is characterized by redness, swelling, elevated temperature, pain, and loss of 
function (Okuse, 2007). The percentage of inhibition against edema and the percentage of anti-
inflammation in all groups of rats are shown in Figure 2 and Table V. 
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Figure 2. Percentage of the volume of edema in rat’s footpad in each treatment group 
 
 
Table V. Percentage of anti-inflammatory inhibition in all group 
 
Groups Percentage of anti-inflammatory 
(%) 
Negative control (CMC-
Na) 
0 
Positive control 73.43 
Eel oil 1500 mg/kg b.w. 34.35 
Eel oil 3000 mg/kg b.w. 35.13 
Eel oil 6000 mg/kg b.w. 40.28 
 
 
Based on Figure 2 and Table V, the positive control (potassium diclofenac) appears to 
experience a decrease in the volume of edema when compared with the negative control. CMC-Na as 
the negative control has no anti-inflammatory effect (no inflammatory response), indicating that the 
test method is valid. Diclofenac is a proven and commonly prescribed nonsteroidal anti-inflammatory 
drug (NSAID) that has analgesic, anti-inflammatory, and antipyretic properties, and is useful in 
treating a variety of acute and chronic pain and inflammatory conditions. Diclofenac exerts its action 
via inhibition of prostaglandin synthesis by preventing the actions of cyclooxygenase-1 (COX-1) and 
cyclooxygenase-2 (COX-2) with equipotency (Gan, 2010). The administration of eel oil at the doses of 
1500, 3000, and 6000 mg/kg b.w. produced anti-inflammatory effects with the percentages of 34.35%, 
35.13%, and 40.28%, respectively. The dose of 6000 mg/kg b.w. yields the highest anti-inflammatory 
response, and the statistical test results showed that it is significantly different (p≤ 0.05) from the 
effects produced by the other two doses. However, the doses of 1500 and 3000 mg/kg b.w. stimulate 
anti-inflammatory reactions that do not differ significantly (p≥ 0.05). This finding is explained by Rees 
et al. (2006), which state that fish oils containing EPA and DHA give a significant effect at a dose of 
1350 mg/kg b.w. Another study proves that at a dose of 1.2 grams, EPA and DHA can substitute the 
effects of NSAIDs (Maroon and Bost, 2006). Many studies have also confirmed that EPA and DHA 
have anti-inflammatory effects (Camuesco et al., 2005; Simopoulos, 2002). EPA and DHA induce the 
down-regulation of pro-inflammatory cytokines, which are associated with the etiology of metabolic 
syndrome, NF-κB transcriptional activity, and upstream cytoplasmic signaling events. Immune 
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responses are dynamic, and the present study suggests a nutrient-sensitive window of LPS activation at 
which EPA and DHA are strongly anti-inflammatory (Mullen et al., 2010). 
 
CONCLUSION  
 The results showed that eel oil had a potential analgesic activity with a significance value of p< 
0.05 compared with the positive and negative controls. In the acetic acid-induced writhing test, the 
analgesic effect is noticeable when eel oil is administered at the doses of 2400, 4800 and, 9600 mg/kg 
b.w. Meanwhile, in the hot plate test, eel oil is efficacious as pain relief when given at the doses of 
4800 and 9600 mg/kg b.w. Based on the anti-inflammatory analysis, the eel oil at the doses of 1500, 
3000, and 6000 mg/kg b.w. can inhibit inflammation by 34.35, 35.132, and 40.28%, respectively. 
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